Sugi Predict

Sugi Predict / Compounds / SCHEMBL1154066

SCHEMBL1154066

SCHEMBL1154066

O=C(O)c1ccc(-c2ccc(CCNC(=O)c3cc(Cl)ccc3OCCc3ccccc3)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.55
▸ DNMT3A Q9Y6K1 1/20 0.53
▸ LMNA P02545 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ PTGER4 P35408 1/20 0.51
▸ HDAC1 Q13547 2/20 0.50
▸ HDAC6 Q9UBN7 2/20 0.50
▸ PTGER1 P34995 1/20 0.50
▸ NLRP3 Q96P20 3/20 0.49
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ PDE4A P27815 1/20 0.47
▸ PDE4B Q07343 1/20 0.47
▸ PDE4C Q08493 1/20 0.47
▸ PDE4D Q08499 1/20 0.47
▸ MCHR1 Q99705 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ HIF1A Q16665 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1153667 0.91 AKR1C3 (0.53) AKR1C3DNMT3ALMNAMAPTPTGER4
SCHEMBL1154709 0.90 DNMT3A (0.56) AKR1C3DNMT3AMAPTPTGER4HDAC1
SCHEMBL1154387 0.89 DNMT3A (0.55) AKR1C3DNMT3APTGER4HDAC1HDAC6
SCHEMBL4014415 0.89 PTGER4 (0.64) AKR1C3LMNAMAPTPTGER4PTGER1
SCHEMBL1154004 0.88 PTPN11 (0.57) DNMT3APTGER4HDAC1HDAC6NLRP3
SCHEMBL1154190 0.88 DNMT3A (0.52) AKR1C3DNMT3ALMNAMAPTPTGER4
SCHEMBL1154619 0.88 DNMT3A (0.52) AKR1C3DNMT3ALMNAMAPTPTGER4
SCHEMBL1154293 0.88 DNMT3A (0.58) AKR1C3DNMT3AMAPTPTGER4HDAC1
SCHEMBL1154301 0.87 DNMT3A (0.53) AKR1C3DNMT3APTGER4HDAC1HDAC6
SCHEMBL1153959 0.87 DNMT3A (0.51) AKR1C3DNMT3ALMNAMAPTPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8299123-B2 CCR10 antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-10-30 — — US disclosed
US-8299123-B2 CCR10 antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-10-30 — — US disclosed
US-8299123-B2 CCR10 antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-10-30 — — US disclosed
EP-2215065-B1 CCR10 ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2012-07-11 — — EP disclosed
EP-2215065-B1 CCR10 ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2012-07-11 — — EP disclosed
US-20110039851-A1 CCR10 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-02-17 — — US disclosed
US-20110039851-A1 CCR10 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-02-17 — — US disclosed
US-20110039851-A1 CCR10 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-02-17 — — US disclosed
EP-2215065-A1 CCR10 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2010-08-11 — — EP disclosed
WO-2009052078-A1 CCR10 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 — — WO disclosed
WO-2009052078-A1 CCR10 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039851-A1 CCR10 ANTAGONISTS CCR10, CCR1, CCR4 AKR1C3 680/4885DNMT3A 4688/4885LMNA 1915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.